Skip to content

The comparison between high dose suppository Diclofenac and Pethidine in post cesarean section pain relief

The comparison between high dose suppository Diclofenac and Pethidine in post cesarean section pain relief

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220903055861N1
Enrollment
90
Registered
2023-06-06
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post C-section pain.

Interventions

Intervention 1: Intervention group: 200 mg diclofenac suppository. Intervention 2: Intervention group: Intramuscular injection pethidine g/mg1. Intervention 3: Control group: 100 mg diclofenac supposi

Sponsors

Alborz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Full-term Pregnant women Aside C-section indication Full-term alive neonate Age between 18 and 45 year Participation consent

Exclusion criteria

Exclusion criteria: Patients who show an allergic reaction to the drug will be excluded from the study History of allergy to NSAID and pethidine Bronchial asthma Drug addiction, alcohol abuse, opium addict or the use of any drug that impairs the perception of pain Proctitis Coagulopathy Gastrointestinal tract ulcers, stomach ulcers, history of gastrointestinal bleeding Long-term steroid treatment or continuous use of painkillers Neurological or psychological disorders Users of medications that interact with pethidine, such as MAO inhibitors (e.g., isocarboxazid , methylene blue, linezolid), certain pain medications (e.g., pentazocine, nalbuphine, butorphanol), seizure medications (e.g., carbamazepine, phenytoin) Liver and kidney diseases

Design outcomes

Primary

MeasureTime frame
Patient's pain according to visual measurement criteria. Timepoint: 2 and 6 hour after C-section. Method of measurement: Visual measurement criteria.

Secondary

MeasureTime frame
Drowsiness. Timepoint: 2 and 6 hour after C-section. Method of measurement: Glasgow Coma Scale.;Hypotension. Timepoint: 2 and 6 hour after C-section. Method of measurement: Sphygmomanometer.;Abnormal bleeding. Timepoint: 2 and 6 hour after C-section. Method of measurement: Physical exam.;Respiratory disfunction. Timepoint: 2 and 6 hour after C-section. Method of measurement: Spirometry and clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham sadat Oliaei

Alborz University of Medical Sciences

elhamoliaei70@gmail.com+98 919 878 9818

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026